@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { ns1:cause . } sub:provenance { sub:assertion prov:generatedAtTime "2021-12-16T19:36:06.327173"^^xsd:dateTime; prov:wasGeneratedBy "S&T TWOC project version 2" . sub:version prov:value "2"^^xsd:integer . rdf:OBJECT rdfs:label "significant reduction in the release of TNFα , IL-6 , IL-1β and IL-8" . rdf:OBJECT-POSITION rdfs:label "-2"^^xsd:integer . rdf:PREDICATE rdfs:label "caused" . rdf:PREDICATE-POSITION rdfs:label "[51]" . rdf:SUBJECT rdfs:label "pre-treatment with dexamethasone ( 100 nM )" . rdf:SUBJECT-POSITION rdfs:label "18"^^xsd:integer . rdfs:ABSTRACT-UID ns3:50 "z9oyrkzt" . rdfs:SENTENCE rdfs:label "However, pre-treatment with dexamethasone (100 nM) caused significant reduction in the release of TNFα, IL-6, IL-1β and IL-8." . rdfs:TRIPLE-UID ns2:z9oyrkzt-TRIPLE-ABSTRACT-1 "z9oyrkzt-TRIPLE-ABSTRACT-1" . rdfs:label "dexamethasone" . rdfs:label "il-6" . } sub:pubInfo { sub:assertion prov:wasDerivedFrom . sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "OWq6rywgEczLO4TrkVdXcgpO1IQwN9jXx49G1EHQatoqZgSPv5SCNCotbEgMWDyqdGwXM9G5UYFe1KvZ1ClJRp+Nf+9f6Au5Mxs3jk4G98OLGlxQkwVUz6wHkgdd6O+LsWLKSRq3F+egQE5Id1fiCgRCM5e/Tqgw8eV32KnScTQ="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-12-16T19:36:06.327173"^^xsd:dateTime; prov:wasAttributedTo . }